Clinical trial
Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney…
NCT00003553 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00003553 |
|---|---|
| Title | Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer |
| Official title | A Phase II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation for Metastatic Renal Cell Carcinoma Followed by Allogeneic T-Cell Infusion as Adoptive Immunotherapy |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Other |
| Interventions | HLA Matched Peripheral BLood Stem Cells |
| Enrollment | 156 |
| Start date | Feb 9, 1998 |
| Primary completion | Jun 27, 2011 |
| Completion | Jun 27, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 19, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: